March 2020 FDA Recall Drug by Mylan Pharmaceuticals Inc.
D-1031-2020 - Presence of particulate matter. presence of metal particles.

This Class II drug recall was voluntarily initiated by Mylan Pharmaceuticals Inc. on March 9, 2020 for the product Drug. The FDA reported the reason for recall as presence of particulate matter. presence of metal particles.. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1031-2020

Reason for Recall
Presence of particulate matter. presence of metal particles.
Initiated
03-09-2020
Reported
03-25-2020
Quantity
300 100-count bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Mylan Pharmaceuticals Inc.
Distributed Nationwide in the USA
Sotalol HCL Tablets, USP (AF) 80 mg, 100 count bottles, Rx Only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505 USA. NDC 00378-5123-01

Batch or Lot Expiration Information

Lot# 3095754, exp. date 02/2021